Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weisberg

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Leukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.
Leukemia|May 29, 2010
Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CMLE Weisberg, X Deng, H G Choi, et al.
Human Reproduction (Oxford, England)|August 7, 1999
Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active womenI S Fraser, P Lähteenmäki, K Elomaa, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Sexually Transmitted Infections|February 28, 2001
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicideC Coggins, K Blanchard, F Alvarez, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|April 4, 2012
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg, Q Liu, Erik Nelson, et al.
Cancer Research|May 8, 1999
HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene rad17, is overexpressed in colon carcinomaS Bao, M S Chang, D Auclair, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Leukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.
Leukemia|May 29, 2010
Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CMLE Weisberg, X Deng, H G Choi, et al.
Human Reproduction (Oxford, England)|August 7, 1999
Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active womenI S Fraser, P Lähteenmäki, K Elomaa, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Sexually Transmitted Infections|February 28, 2001
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicideC Coggins, K Blanchard, F Alvarez, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|April 4, 2012
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg, Q Liu, Erik Nelson, et al.
Cancer Research|May 8, 1999
HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene rad17, is overexpressed in colon carcinomaS Bao, M S Chang, D Auclair, et al.
Pageof 9